Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Park Avenue Compounding
FDA Inspection
•Park Avenue Compounding•August 28, 2019

Park Avenue Compounding – FDA Inspection, Aug 28, 2019

Record Details

This FDA Inspection record concerns Park Avenue Compounding, with an inspection on August 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Park Avenue Compounding
Inspection Date
August 28, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Mindy M. Chou (FDA Associated Person)
View Company Profile

ID · d5ad6aa9-c8ee-478a-a078-e2b5877ef49b

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1100607
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 211.165(d)Acceptance criteria for sampling & testing
  2. 21 CFR 211.46(a)Adequate ventilation not provided
  3. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  4. 21 CFR 211.28(a)Clothing appropriate for duties performed
  5. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  6. 21 CFR 211.113(b)Procedures for sterile drug products
  7. 21 CFR 211.165(a)Testing and release for distribution
  8. 21 CFR 211.160(b)(1)Sampling and testing procedures described

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Park Avenue Compounding

5
DateClassificationOfficeProject area
September 23, 2025Not classifiedKansas City District OfficeDrug Quality Assurance
February 8, 2024OAIDrug Quality Assurance
November 16, 2017OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 14, 2014OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 5, 2009NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
Other documents for Park Avenue Compounding
  • FDA Inspection 1283044 - 2025-09-23
  • FDA Inspection 1231487 - 2024-02-08
  • FDA Inspection 1033886 - 2017-11-16
  • FDA Inspection 892077 - 2014-08-14
  • FDA Inspection 609213 - 2009-08-05

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Park Avenue Compounding
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.